418 related articles for article (PubMed ID: 22275372)
21. An effective strategy for increasing the radiosensitivity of Human lung Cancer cells by blocking Nrf2-dependent antioxidant responses.
Lee S; Lim MJ; Kim MH; Yu CH; Yun YS; Ahn J; Song JY
Free Radic Biol Med; 2012 Aug; 53(4):807-16. PubMed ID: 22684019
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of NF-E2-related factor-2-dependent glutathione by carnosol provokes a cytoprotective response and enhances cell survival.
Chen CC; Chen HL; Hsieh CW; Yang YL; Wung BS
Acta Pharmacol Sin; 2011 Jan; 32(1):62-9. PubMed ID: 21151161
[TBL] [Abstract][Full Text] [Related]
23. Inhibitor of Nrf2 (INrf2 or Keap1) protein degrades Bcl-xL via phosphoglycerate mutase 5 and controls cellular apoptosis.
Niture SK; Jaiswal AK
J Biol Chem; 2011 Dec; 286(52):44542-56. PubMed ID: 22072718
[TBL] [Abstract][Full Text] [Related]
24. Site-directed mutagenesis of cysteine to serine in the DNA binding region of Nrf2 decreases its capacity to upregulate antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene.
Bloom D; Dhakshinamoorthy S; Jaiswal AK
Oncogene; 2002 Mar; 21(14):2191-200. PubMed ID: 11948402
[TBL] [Abstract][Full Text] [Related]
25. Tyrosine phosphorylation controls nuclear export of Fyn, allowing Nrf2 activation of cytoprotective gene expression.
Kaspar JW; Jaiswal AK
FASEB J; 2011 Mar; 25(3):1076-87. PubMed ID: 21097520
[TBL] [Abstract][Full Text] [Related]
26. Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants.
Dhakshinamoorthy S; Jain AK; Bloom DA; Jaiswal AK
J Biol Chem; 2005 Apr; 280(17):16891-900. PubMed ID: 15734732
[TBL] [Abstract][Full Text] [Related]
27. Nuclear factor erythroid 2-related factor 2 enhances carcinogenesis by suppressing apoptosis and promoting autophagy in nickel-transformed cells.
Son YO; Pratheeshkumar P; Divya SP; Zhang Z; Shi X
J Biol Chem; 2017 May; 292(20):8315-8330. PubMed ID: 28330870
[TBL] [Abstract][Full Text] [Related]
28. Aberrantly elevated redox sensing factor Nrf2 promotes cancer stem cell survival via enhanced transcriptional regulation of ABCG2 and Bcl-2/Bmi-1 genes.
Jia Y; Chen J; Zhu H; Jia ZH; Cui MH
Oncol Rep; 2015 Nov; 34(5):2296-304. PubMed ID: 26324021
[TBL] [Abstract][Full Text] [Related]
29. Zerumbone protects human skin keratinocytes against UVA-irradiated damages through Nrf2 induction.
Yang HL; Lee CL; Korivi M; Liao JW; Rajendran P; Wu JJ; Hseu YC
Biochem Pharmacol; 2018 Feb; 148():130-146. PubMed ID: 29273513
[TBL] [Abstract][Full Text] [Related]
30. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.
Shi L; Wu L; Chen Z; Yang J; Chen X; Yu F; Zheng F; Lin X
Cell Physiol Biochem; 2015; 35(6):2333-48. PubMed ID: 25896253
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of Nrf2 by the combination of TRAIL and Valproic acid induces apoptotic cell death of TRAIL-resistant papillary thyroid cancer cells via suppression of Bcl-xL.
Cha HY; Lee BS; Chang JW; Park JK; Han JH; Kim YS; Shin YS; Byeon HK; Kim CH
Cancer Lett; 2016 Mar; 372(1):65-74. PubMed ID: 26721202
[TBL] [Abstract][Full Text] [Related]
32. The involvement of Nrf2-ARE pathway in regulation of apoptosis in human glioblastoma cell U251.
Pan H; Wang H; Zhu L; Wang X; Cong Z; Sun K; Fan Y
Neurol Res; 2013 Jan; 35(1):71-8. PubMed ID: 23006842
[TBL] [Abstract][Full Text] [Related]
33. Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype.
Singh A; Wu H; Zhang P; Happel C; Ma J; Biswal S
Mol Cancer Ther; 2010 Aug; 9(8):2365-76. PubMed ID: 20682644
[TBL] [Abstract][Full Text] [Related]
34. Topoisomerase inhibitor-induced apoptosis accompanied by down-regulation of Bcl-2 in human lung cancer cells.
Oizumi S; Isobe H; Ogura S; Ishida T; Yamazaki K; Nishimura M; Kawakami Y; Dosaka-Akita H
Anticancer Res; 2002; 22(6C):4029-37. PubMed ID: 12553028
[TBL] [Abstract][Full Text] [Related]
35. The chalcone compound isosalipurposide (ISPP) exerts a cytoprotective effect against oxidative injury via Nrf2 activation.
Han JY; Cho SS; Yang JH; Kim KM; Jang CH; Park DE; Bang JS; Jung YS; Ki SH
Toxicol Appl Pharmacol; 2015 Aug; 287(1):77-85. PubMed ID: 26028482
[TBL] [Abstract][Full Text] [Related]
36. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
[TBL] [Abstract][Full Text] [Related]
37. Nrf2-Keap1 antioxidant defense and cell survival signaling are upregulated by 17β-estradiol in homocysteine-treated dopaminergic SH-SY5Y cells.
Chen CS; Tseng YT; Hsu YY; Lo YC
Neuroendocrinology; 2013; 97(3):232-41. PubMed ID: 22948038
[TBL] [Abstract][Full Text] [Related]
38. Nomilin inhibits metastasis via induction of apoptosis and regulates the activation of transcription factors and the cytokine profile in B16F-10 cells.
Pratheeshkumar P; Raphael TJ; Kuttan G
Integr Cancer Ther; 2012 Mar; 11(1):48-60. PubMed ID: 21665879
[TBL] [Abstract][Full Text] [Related]
39. Alkylating Agent-Induced NRF2 Blocks Endoplasmic Reticulum Stress-Mediated Apoptosis via Control of Glutathione Pools and Protein Thiol Homeostasis.
Zanotto-Filho A; Masamsetti VP; Loranc E; Tonapi SS; Gorthi A; Bernard X; Gonçalves RM; Moreira JC; Chen Y; Bishop AJ
Mol Cancer Ther; 2016 Dec; 15(12):3000-3014. PubMed ID: 27638861
[TBL] [Abstract][Full Text] [Related]
40. HOXC6 is deregulated in human head and neck squamous cell carcinoma and modulates Bcl-2 expression.
Moon SM; Kim SA; Yoon JH; Ahn SG
J Biol Chem; 2012 Oct; 287(42):35678-35688. PubMed ID: 22896703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
